Numis SC + AIM ex. Investment Co's Index (capital gains)
1750.0
5086.9
-8.1%
-28.5%
+190.7%
Russell 2000 Technology Index (capital gains in Sterling terms)
673.8
***
3973.4
-6.7%
-25.6%
+489.7%
Share price
90.9
p****
1634.0
p
-2.5%
-34.8%
+1697.6%
Premium/(Discount) to NAV (excl accrued income)/share as at 30 September 2022
(19.1)%
UK Equity Portfolio as a % of Net Asset Value at 30 September 2022*****
44.4%
Overseas Equity Portfolio as a % of Net Asset Value at 30 September 2022
44.3%
Cash as a % of Net Asset Value at 30 September 2022******
11.3%
Number of Equity Holdings at 30 September 2022
352
*100p was the subscription price before launch costs of 1.3p
** Total return (in percentage terms) on 98.7p invested at inception excluding warrants.
***Value shown is from 31/03/1996 the date the funds were globalised.
****90.9p is CGT base subscription price for shareholders adjusting for warrants which were issued on a 1 for 5 basis.
*****Includes 7 convertible bonds.
****** The company is not currently geared.
These figures are not audited
At 30th September 2022 the Net Asset Value including current year income was £1,274.0m (£1,274.6m excluding current year income). Income is shown net of expenses.
There are 63,119,545 shares currently in issue.
This Report has been issued on behalf of Herald Investment Trust plc, and has been approved by Herald Investment Management Limited, its investment manager. Herald Investment Management Limited is authorised and regulated by the Financial Conduct Authority. Past performance is not a reliable indicator of future returns. Markets and currency movements may cause the value of shares, and the income from them, to fall as well as rise, and you may get back less than you invested when you decide to sell your shares.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.